Werewolf Therapeutics shares surged more than 100% in intraday trading. The move came without immediate public disclosure of the specific catalyst behind the rally.
Further verified details on the reason for the surge were not immediately available.


The biotech company’s shares jumped sharply, though further details on the driver were not immediately available.

Werewolf Therapeutics shares surged more than 100% in intraday trading. The move came without immediate public disclosure of the specific catalyst behind the rally.
Further verified details on the reason for the surge were not immediately available.

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →

